What is it about?
This review report the therapeutic and adverse effects of cariprazine, a partial agonist at D2 and D3 receptors. This new antipsychotic drug can be used to treat schizophrenia and mania in bipolar disorder
Featured Image
Why is it important?
This review about cariprazine summarizes the pharmacokinetics, the pharmacological effect and the results of clinical studies in the treatment of schizophrenia and bipolar disorder
Perspectives
In september 2015, cariprazine was generally approved
Dr Felix-Martin Werner
Euro Akademie Pößneck
Read the Original
This page is a summary of: New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine, Therapeutics and Clinical Risk Management, November 2015, Dove Medical Press,
DOI: 10.2147/tcrm.s64915.
You can read the full text:
Contributors
The following have contributed to this page
